Ruklanthi de Alwis

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Prefrontal Cortex

Top Venues

Emerging microbes & infections

Current treatment options in infectious diseases

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Charles Kevin Tiu, Feng Zhu, Lin-Fa Wang, Ruklanthi de Alwis
Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput Serology. Pathogens (Basel, Switzerland) 11 (5) (2022)
Bernice Ling Zhi Oh, Nicole Tan, Ruklanthi de Alwis, Kamini Kunasegaran, Zhiwei Chen, Michelle Poon, Esther Chan, Jenny G H Low, Allen Eng-Juh Yeoh, Antonio Bertoletti, Nina Le Bert
Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients. Blood 140 (2) (2022)
Ruklanthi de Alwis, Raphaël M Zellweger, Edmond Chua, Lin-Fa Wang, Tanu Chawla, October Michael Sessions, Damien Marlier, John E Connolly, Veronika von Messling, Danielle E Anderson
Systemic inflammation, innate immunity and pathogenesis after Zika virus infection in cynomolgus macaques are modulated by strain-specificity within the Asian lineage. Emerging microbes & infections 10 (1) (2021)
Amanda Makha Bifani, Eugenia Z Ong, Ruklanthi de Alwis
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever. Current treatment options in infectious diseases (2020)